Approach to concurrent coronary and carotid artery disease: Epidemiology, screening and treatment

Patrícia Feitosa Frota Dos Reis1, Pedro Vieira Linhares1, Fábio Grunspun Pitta1

  • 1Department of Atherosclerosis, Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP (InCor-HCFMUSP), São Paulo, SP, Brazil.

Revista Da Associacao Medica Brasileira (1992)
|February 17, 2018
PubMed

Insights

Patients with both coronary artery disease and carotid artery disease face high perioperative risks. This review examines evidence to guide treatment decisions for these complex cardiovascular conditions.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Coronary artery disease (CAD) and carotid artery disease (CeAD) often coexist.
  • Despite advances, perioperative complication risks remain high for patients with concomitant CAD and CeAD.
  • Current literature offers limited guidance on optimal management strategies.

Purpose of the Study:

  • To review existing evidence on managing patients with concurrent CAD and CeAD.
  • To address the lack of consensus on the optimal initial therapeutic approach (myocardial vs. carotid revascularization).
  • To discuss the best surgical techniques, including extracorporeal circulation, hybrid treatments, and other options.

Main Methods:

  • Systematic review of published literature.
  • Analysis of evidence regarding perioperative outcomes.
  • Identification of therapeutic decision-making challenges.

Main Results:

  • Limited evidence exists for managing concomitant CAD and CeAD.
  • Significant disagreement persists regarding the preferred initial revascularization strategy.
  • Optimal surgical techniques and perioperative risk mitigation strategies require further investigation.

Conclusions:

  • Managing patients with concomitant CAD and CeAD presents significant challenges.
  • Further research is needed to establish evidence-based guidelines for treatment sequencing and technique selection.
  • Pragmatic questions are raised to aid clinicians in therapeutic decision-making for this high-risk population.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K